Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
McConnachie, L
Los resultados de los ensayos en cuanto a la obesidad son claros: el 96% de los que tomaron el frmaco redujeron al menos un 5% de peso, y 4 de cada 10 lograron ms de un 25%
Additional Cost Management Strategies Organizations exploring GLP-1 coverage are also considering targeted cost-control measures, including: Setting clinical qualification standards based on BMI and related conditions Establishing duration or lifetime coverage limits where allowed Adjusting copays or deductibles for obesity-related medications Favoring lower-utilization or lower-cost therapeutic alternatives within the formulary Evaluating alternative treatments such as bariatric surgery, which may produce durable outcomes at comparable costs to a year of medication therapy These strategies allow employers to maintain access while aligning coverage with financial objectives
Creating dedicated in-store sections: Providing specific areas for GLP-1 friendly products, making it easier for customers to find suitable options
